Purchase Order HT001416P0842

Award Date 3/31/16
Potential Completion Date 4/5/16
Potential Value $39K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frisco, TX 75034, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to US Bioservices Corporation, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a for-profit organization. The contract, valued at $36,878.60, is to provide the CS-1000 CARTICEL product. There was no set-aside designation for this award. US Bioservices Corporation specializes in supplying high-cost specialty pharmaceuticals, such as Revlimid, Pomalyst, and Balversa, to the Department of Veterans...
This is a firm fixed price purchase order awarded by the Defense Health Agency to US Bioservices Corporation, a for-profit organization that provides pharmaceuticals to government agencies. The contract is to deliver the medication CS-1000 CARTICEL, with a total ceiling value of $36,878.60 and a completion date of December 18, 2015. The contract does not have a set-aside designation. US Bioservices Corporation is a subsidiary of the parent company Cencora, Inc., which operates under the Doing...
This is a firm-fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to US Bioservices Corporation, a for-profit pharmaceutical provider, for the delivery of CARTICEL CARE CULTURED CHONDROCYTES. The contract has a ceiling value of $75,000.00 and a performance period ending on January 5, 2017. There is no set-aside designation for this award. US Bioservices Corporation has received over 150 prime federal contract awards from the Department of Veterans Affairs...
This federal contract award to US Bioservices Corporation, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a firm fixed-price purchase order from the Defense Health Agency. The award, valued at $36,878.60, is to provide specialty pharmaceuticals such as Revlimid, Pomalyst, and Balversa to treat conditions like multiple myeloma and bladder cancer. The contract has no set-aside designation and was awarded on January 20, 2016, with a completion date of January 29, 2016. US...
This federal contract award, valued at $20,286.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This is a $29,894.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $87,010.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora,...
This federal contract award, valued at $98,042.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,438.50 firm fixed-price contract covers the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $15,673.68, is a delivery order for pharmaceutical products and medical supplies to support federal healthcare programs, particularly within military and veterans' healthcare systems. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...

This is a $38,564 firm-fixed-price purchase order awarded by the Defense Health Agency to US Bioservices Corporation, a for-profit pharmaceutical provider. The contract is for the supply of the medication CS-1000 CARTICEL, with a period of performance ending on April 5, 2016. US Bioservices Corporation is a subsidiary of the parent company Cencora, Inc., which operates under the Doing Business As name Amerisourcebergen. US Bioservices Corporation has received over 150 prime federal contract awards from the Department of Veterans Affairs Veterans Health Administration since 2019 to provide specialty medications such as Revlimid, Pomalyst, and Balversa to treat conditions like multiple myeloma and bladder cancer. This award did not have a set-aside designation.

Generated 7/27/24, 9:39 AM